Records containing: Medullary Thyroid Cancer (MTC)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-02Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-07-03A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations
-
CLINICAL_TRIALS study record update · 2024-07-09A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2021-02-11Phase II Trial of Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2020-07-31A Phase II Study Exploring the Safety and Efficacy of Nintedanib (BIBF1120) as Second Line Therapy for Patients With Either Differentiated or Medullary Thyroid Cancer Progressing After First Line Therapy.
- Organize your saved records without ads with Plus.